Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lower Oesophagus Cancer”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Ended earlyNCT01830270
What this trial is testing

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

Who this might be right for
Stomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)UnknownNCT00674167
What this trial is testing

The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 21
Not applicableStudy completedNCT01047111
What this trial is testing

Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)

Who this might be right for
Esophageal Neoplasms
Fudan University 300
Not applicableStudy completedNCT01807936
What this trial is testing

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

Who this might be right for
Esophageal Neoplasms
Fudan University 400
Testing effectiveness (Phase 2)Study completedNCT01197885
What this trial is testing

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Who this might be right for
Solid Tumors
Ganymed Pharmaceuticals GmbH 54
Large-scale testing (Phase 3)UnknownNCT02448979
What this trial is testing

Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 800
Not applicableStudy completedNCT01341197
What this trial is testing

Fecal Screening Assay for Taiwanese Population

Who this might be right for
Advanced Colorectal NeoplasmsThroat CancerEsophageal Cancer+2 more
National Taiwan University Hospital 3,172
Testing effectiveness (Phase 2)Ended earlyNCT01457846
What this trial is testing

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Who this might be right for
Gastro-oesophageal Junction CancerGastric Cancer
AstraZeneca 960
Large-scale testing (Phase 3)UnknownNCT01053182
What this trial is testing

Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches

Who this might be right for
Esophageal CancerPostoperative ComplicationsDiaphragm+1 more
Sichuan University 320
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Not applicableEnded earlyNCT00737802
What this trial is testing

In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter

Who this might be right for
GERDBarretts Esophagus
Northwell Health 4
Early research (Phase 1)Study completedNCT01671774
What this trial is testing

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Gastric AdenocarcinomaCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of Esophagus
Astellas Pharma Global Development, Inc. 29
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Not applicableStudy completedNCT05617352
What this trial is testing

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study

Who this might be right for
Esophageal Cancer
Yongtao Han 1,659
Large-scale testing (Phase 3)UnknownNCT00450203
What this trial is testing

Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer

Who this might be right for
Oesophagogastric Cancer
Professor David Cunningham 1,103
Testing effectiveness (Phase 2)Study completedNCT00411151
What this trial is testing

Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaBarrett Esophagus
Johannes Gutenberg University Mainz 52
Not applicableUnknownNCT05812495
What this trial is testing

Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis

Who this might be right for
Epiphora Due to Insufficient Drainage, Left SideEpiphora Due to Insufficient Drainage, Right Side
Tianjin Medical University Cancer Institute and Hospital 402
Testing effectiveness (Phase 2)Study completedNCT01020630
What this trial is testing

Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 91
Not applicableStudy completedNCT04683601
What this trial is testing

Generation of a Surgical Field in the Left Lateral Decubitus Position

Who this might be right for
Esophageal CancerThoracic Diseases
Shizuoka Cancer Center 154
Testing effectiveness (Phase 2)Study completedNCT00107341
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 37
Load More Results